Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Cytochrome P450 function and pharmacological roles in inflammation and cancer / / edited by James P. Hardwick, S. J. Enna, Lynn Lecount ; contributors, Mohamed A. Abdelmegeed [and thirty-three others]
| Cytochrome P450 function and pharmacological roles in inflammation and cancer / / edited by James P. Hardwick, S. J. Enna, Lynn Lecount ; contributors, Mohamed A. Abdelmegeed [and thirty-three others] |
| Edizione | [First edition.] |
| Pubbl/distr/stampa | Amsterdam, [Netherlands] : , : Academic Press, , 2015 |
| Descrizione fisica | 1 online resource (506 p.) |
| Disciplina | 572.7 |
| Collana | Advances in Pharmacology |
| Soggetto topico | Cytochrome P-450 |
| Soggetto genere / forma | Electronic books. |
| ISBN |
0-12-803120-4
0-12-803119-0 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Cytochrome P450 Function and Pharmacological Roles in Inflammation and Cancer; Copyright; Contents; Contributors; Preface; References; Chapter One: Role of Cytochrome P450 Monooxygenase in Carcinogen and Chemotherapeutic Drug Metabolism; 1. Introduction; 2. Historical Aspects of Chemical Carcinogenesis Leading to Discovery of the Cytochrome P450 Monooxygenase; 2.1. Cytochromes P450; 2.2. Butter Yellow Carcinogenesis; 2.3. PAH Carcinogenesis: Protein Adducts and Induction of Metabolism
3. Cytochrome P450-Monooxygenase-Mediated Activation of Procarcinogen and Chemotherapeutic Prodrugs3.1. Aromatic Azo Compounds; 3.2. Polycyclic Aromatic Hydrocarbons; 3.3. Polychlorinated Biphenyls; 3.3.1. Polychlorinated Biphenyls with Low Chlorine Content; 3.3.2. Highly Chlorinated Biphenyls; 3.4. Vinyl Chloride; 3.5. Nitrosamines; 3.6. Furans; 3.7. Chemotherapeutic Prodrugs; 3.7.1. Cyclophosphamide; 3.7.2. Procarbazine and Other Hydrazine Derivatives; 3.7.3. Anthracycline Antibiotics; 4. Factors That Regulate Changes in Gene Expression: Differences Between Rodents and Humans 4.1. Hepatic Nuclear Receptors and Enzyme Induction4.2. Differences Between Rodent and Human Receptors; 4.3. CAR Splice Variants and Ligand Specificity; 4.4. Exogenous Compounds Acting on the PPAR; 4.5. Underlying Regulation by Other Hormones and Transcription Factors; 4.6. Effects of Environmental Agents; 5. Polymorphic Cytochrome P450 Variants Impacting Expression and Cancer Susceptibility; 5.1. Cytochrome P4501A1 and Glutathione S-Transferase M1; 5.2. Cytochrome P4502D6 and Cytochrome P4502E1; 6. Conclusion; Conflict of Interest; Acknowledgment; References Chapter Two: Involvement of Cytochrome P450 in Reactive Oxygen Species Formation and Cancer1. Introduction; 2. Reactive Oxygen Species Formation in Biological Systems; 2.1. Oxygen Reactivity and Formation of Reactive Oxygen Species; 2.2. Types of Reactive Oxygen Species and Their Reactivities; 2.2.1. Superoxide Radical Anion; 2.2.2. Hydrogen Peroxide; 2.2.3. Hydroxyl Radical; 2.2.4. Peroxyl Radical; 2.2.5. Singlet Oxygen; 3. Protective Agents to Combat Reactive Oxygen Species; 3.1. Antioxidants; 3.1.1. Antioxidant Enzymes; 3.1.2. Nonenzymatic Antioxidants; 3.1.2.1. Glutathione 3.1.2.2. Vitamin E, Vitamin C, and β-Carotene3.1.2.3. Lycopene; 3.1.2.4. Melatonin; 4. CYP Catalytic Cycle and Involvement of CYP Enzymes in Reactive Oxygen Species Formation; 5. Roles of Reactive Oxygen Species in Cancer; 5.1. Reactive Oxygen Species and Cell Signaling; 6. Relationship Between CYP Enzymes and Cancer; 6.1. CYP Expression in Neoplastic Tissues; 6.2. CYP Polymorphism and Cancer Risk; 6.3. CYP Enzymes and Chemical Carcinogenesis; 6.4. CYP Enzymes and Cancer Therapy; 7. Conclusion; Conflict of Interest; Acknowledgments; References Chapter Three: Polymorphic Variants of Cytochrome P450: Relevance to Cancer and Other Diseases |
| Record Nr. | UNINA-9910460911303321 |
| Amsterdam, [Netherlands] : , : Academic Press, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cytochrome P450 function and pharmacological roles in inflammation and cancer / / edited by James P. Hardwick, S. J. Enna, Lynn Lecount ; contributors, Mohamed A. Abdelmegeed [and thirty-three others]
| Cytochrome P450 function and pharmacological roles in inflammation and cancer / / edited by James P. Hardwick, S. J. Enna, Lynn Lecount ; contributors, Mohamed A. Abdelmegeed [and thirty-three others] |
| Edizione | [First edition.] |
| Pubbl/distr/stampa | Amsterdam, [Netherlands] : , : Academic Press, , 2015 |
| Descrizione fisica | 1 online resource (506 p.) |
| Disciplina | 572.7 |
| Collana | Advances in Pharmacology |
| Soggetto topico | Cytochrome P-450 |
| ISBN |
0-12-803120-4
0-12-803119-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Cytochrome P450 Function and Pharmacological Roles in Inflammation and Cancer; Copyright; Contents; Contributors; Preface; References; Chapter One: Role of Cytochrome P450 Monooxygenase in Carcinogen and Chemotherapeutic Drug Metabolism; 1. Introduction; 2. Historical Aspects of Chemical Carcinogenesis Leading to Discovery of the Cytochrome P450 Monooxygenase; 2.1. Cytochromes P450; 2.2. Butter Yellow Carcinogenesis; 2.3. PAH Carcinogenesis: Protein Adducts and Induction of Metabolism
3. Cytochrome P450-Monooxygenase-Mediated Activation of Procarcinogen and Chemotherapeutic Prodrugs3.1. Aromatic Azo Compounds; 3.2. Polycyclic Aromatic Hydrocarbons; 3.3. Polychlorinated Biphenyls; 3.3.1. Polychlorinated Biphenyls with Low Chlorine Content; 3.3.2. Highly Chlorinated Biphenyls; 3.4. Vinyl Chloride; 3.5. Nitrosamines; 3.6. Furans; 3.7. Chemotherapeutic Prodrugs; 3.7.1. Cyclophosphamide; 3.7.2. Procarbazine and Other Hydrazine Derivatives; 3.7.3. Anthracycline Antibiotics; 4. Factors That Regulate Changes in Gene Expression: Differences Between Rodents and Humans 4.1. Hepatic Nuclear Receptors and Enzyme Induction4.2. Differences Between Rodent and Human Receptors; 4.3. CAR Splice Variants and Ligand Specificity; 4.4. Exogenous Compounds Acting on the PPAR; 4.5. Underlying Regulation by Other Hormones and Transcription Factors; 4.6. Effects of Environmental Agents; 5. Polymorphic Cytochrome P450 Variants Impacting Expression and Cancer Susceptibility; 5.1. Cytochrome P4501A1 and Glutathione S-Transferase M1; 5.2. Cytochrome P4502D6 and Cytochrome P4502E1; 6. Conclusion; Conflict of Interest; Acknowledgment; References Chapter Two: Involvement of Cytochrome P450 in Reactive Oxygen Species Formation and Cancer1. Introduction; 2. Reactive Oxygen Species Formation in Biological Systems; 2.1. Oxygen Reactivity and Formation of Reactive Oxygen Species; 2.2. Types of Reactive Oxygen Species and Their Reactivities; 2.2.1. Superoxide Radical Anion; 2.2.2. Hydrogen Peroxide; 2.2.3. Hydroxyl Radical; 2.2.4. Peroxyl Radical; 2.2.5. Singlet Oxygen; 3. Protective Agents to Combat Reactive Oxygen Species; 3.1. Antioxidants; 3.1.1. Antioxidant Enzymes; 3.1.2. Nonenzymatic Antioxidants; 3.1.2.1. Glutathione 3.1.2.2. Vitamin E, Vitamin C, and β-Carotene3.1.2.3. Lycopene; 3.1.2.4. Melatonin; 4. CYP Catalytic Cycle and Involvement of CYP Enzymes in Reactive Oxygen Species Formation; 5. Roles of Reactive Oxygen Species in Cancer; 5.1. Reactive Oxygen Species and Cell Signaling; 6. Relationship Between CYP Enzymes and Cancer; 6.1. CYP Expression in Neoplastic Tissues; 6.2. CYP Polymorphism and Cancer Risk; 6.3. CYP Enzymes and Chemical Carcinogenesis; 6.4. CYP Enzymes and Cancer Therapy; 7. Conclusion; Conflict of Interest; Acknowledgments; References Chapter Three: Polymorphic Variants of Cytochrome P450: Relevance to Cancer and Other Diseases |
| Record Nr. | UNINA-9910797336403321 |
| Amsterdam, [Netherlands] : , : Academic Press, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cytochrome P450 function and pharmacological roles in inflammation and cancer / / edited by James P. Hardwick, S. J. Enna, Lynn Lecount ; contributors, Mohamed A. Abdelmegeed [and thirty-three others]
| Cytochrome P450 function and pharmacological roles in inflammation and cancer / / edited by James P. Hardwick, S. J. Enna, Lynn Lecount ; contributors, Mohamed A. Abdelmegeed [and thirty-three others] |
| Edizione | [First edition.] |
| Pubbl/distr/stampa | Amsterdam, [Netherlands] : , : Academic Press, , 2015 |
| Descrizione fisica | 1 online resource (506 p.) |
| Disciplina | 572.7 |
| Collana | Advances in Pharmacology |
| Soggetto topico | Cytochrome P-450 |
| ISBN |
0-12-803120-4
0-12-803119-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Cytochrome P450 Function and Pharmacological Roles in Inflammation and Cancer; Copyright; Contents; Contributors; Preface; References; Chapter One: Role of Cytochrome P450 Monooxygenase in Carcinogen and Chemotherapeutic Drug Metabolism; 1. Introduction; 2. Historical Aspects of Chemical Carcinogenesis Leading to Discovery of the Cytochrome P450 Monooxygenase; 2.1. Cytochromes P450; 2.2. Butter Yellow Carcinogenesis; 2.3. PAH Carcinogenesis: Protein Adducts and Induction of Metabolism
3. Cytochrome P450-Monooxygenase-Mediated Activation of Procarcinogen and Chemotherapeutic Prodrugs3.1. Aromatic Azo Compounds; 3.2. Polycyclic Aromatic Hydrocarbons; 3.3. Polychlorinated Biphenyls; 3.3.1. Polychlorinated Biphenyls with Low Chlorine Content; 3.3.2. Highly Chlorinated Biphenyls; 3.4. Vinyl Chloride; 3.5. Nitrosamines; 3.6. Furans; 3.7. Chemotherapeutic Prodrugs; 3.7.1. Cyclophosphamide; 3.7.2. Procarbazine and Other Hydrazine Derivatives; 3.7.3. Anthracycline Antibiotics; 4. Factors That Regulate Changes in Gene Expression: Differences Between Rodents and Humans 4.1. Hepatic Nuclear Receptors and Enzyme Induction4.2. Differences Between Rodent and Human Receptors; 4.3. CAR Splice Variants and Ligand Specificity; 4.4. Exogenous Compounds Acting on the PPAR; 4.5. Underlying Regulation by Other Hormones and Transcription Factors; 4.6. Effects of Environmental Agents; 5. Polymorphic Cytochrome P450 Variants Impacting Expression and Cancer Susceptibility; 5.1. Cytochrome P4501A1 and Glutathione S-Transferase M1; 5.2. Cytochrome P4502D6 and Cytochrome P4502E1; 6. Conclusion; Conflict of Interest; Acknowledgment; References Chapter Two: Involvement of Cytochrome P450 in Reactive Oxygen Species Formation and Cancer1. Introduction; 2. Reactive Oxygen Species Formation in Biological Systems; 2.1. Oxygen Reactivity and Formation of Reactive Oxygen Species; 2.2. Types of Reactive Oxygen Species and Their Reactivities; 2.2.1. Superoxide Radical Anion; 2.2.2. Hydrogen Peroxide; 2.2.3. Hydroxyl Radical; 2.2.4. Peroxyl Radical; 2.2.5. Singlet Oxygen; 3. Protective Agents to Combat Reactive Oxygen Species; 3.1. Antioxidants; 3.1.1. Antioxidant Enzymes; 3.1.2. Nonenzymatic Antioxidants; 3.1.2.1. Glutathione 3.1.2.2. Vitamin E, Vitamin C, and β-Carotene3.1.2.3. Lycopene; 3.1.2.4. Melatonin; 4. CYP Catalytic Cycle and Involvement of CYP Enzymes in Reactive Oxygen Species Formation; 5. Roles of Reactive Oxygen Species in Cancer; 5.1. Reactive Oxygen Species and Cell Signaling; 6. Relationship Between CYP Enzymes and Cancer; 6.1. CYP Expression in Neoplastic Tissues; 6.2. CYP Polymorphism and Cancer Risk; 6.3. CYP Enzymes and Chemical Carcinogenesis; 6.4. CYP Enzymes and Cancer Therapy; 7. Conclusion; Conflict of Interest; Acknowledgments; References Chapter Three: Polymorphic Variants of Cytochrome P450: Relevance to Cancer and Other Diseases |
| Record Nr. | UNINA-9910817147903321 |
| Amsterdam, [Netherlands] : , : Academic Press, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||